• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管内皮生长因子表达增加与肝细胞癌的肿瘤进展相关。

Increased expression of vascular endothelial growth factor is associated with tumor progression in hepatocellular carcinoma.

作者信息

Torimura T, Sata M, Ueno T, Kin M, Tsuji R, Suzaku K, Hashimoto O, Sugawara H, Tanikawa K

机构信息

Second Department of Medicine and Research Center for Innovative Cancer Therapy, Kurume University School of Medicine, Japan.

出版信息

Hum Pathol. 1998 Sep;29(9):986-91. doi: 10.1016/s0046-8177(98)90205-2.

DOI:10.1016/s0046-8177(98)90205-2
PMID:9744316
Abstract

Vascular endothelial growth factor is a potent direct-acting angiogenic factor. Early in hepatocarcinogenesis, hepatocellular carcinomas do not show hypervascularity; at later stages, they require abundant arterial blood flow. We investigated the role of vascular endothelial growth factor in hepatocellular carcinoma arterialization. We studied 51 patients with hepatocellular carcinoma. All patients had undergone hepatic arteriography. Vascular endothelial growth factor expression was investigated by immunohistochemistry (n = 51) and in situ hybridization (n = 13), and the changes in vascular endothelial growth factor expression were evaluated in relation to tumor differentiation and changes in tumor vascularity. The expression of vascular endothelial growth factor isoforms in hepatocellular carcinomas was also analyzed by reverse transcriptase-polymerase chain reaction (n = 10). Vascular endothelial growth factor expression was detected in hepatoma cells and hepatic stellate cells, and increased vascular endothelial growth factor expression was associated with tumor dedifferentiation. Vascular endothelial growth factor expression in hypervascular hepatocellular carcinomas was greater than in those not showing hypervascularity. The major vascular endothelial growth factor isoforms expressed in hepatocellular carcinoma were 121 and 165. These findings indicate that vascular endothelial growth factors 121 and 165 play a critical role in the process of angiogenesis in hepatocellular carcinomas.

摘要

血管内皮生长因子是一种强效的直接作用血管生成因子。在肝癌发生早期,肝细胞癌不表现出血管增多;在后期,它们需要丰富的动脉血流。我们研究了血管内皮生长因子在肝细胞癌动脉化中的作用。我们研究了51例肝细胞癌患者。所有患者均接受了肝动脉造影。通过免疫组织化学(n = 51)和原位杂交(n = 13)研究血管内皮生长因子表达,并根据肿瘤分化和肿瘤血管变化评估血管内皮生长因子表达的变化。还通过逆转录聚合酶链反应(n = 10)分析了肝细胞癌中血管内皮生长因子异构体的表达。在肝癌细胞和肝星状细胞中检测到血管内皮生长因子表达,血管内皮生长因子表达增加与肿瘤去分化相关。高血管性肝细胞癌中的血管内皮生长因子表达高于未表现出血管增多的肝细胞癌。肝细胞癌中表达的主要血管内皮生长因子异构体是121和165。这些发现表明血管内皮生长因子121和165在肝细胞癌血管生成过程中起关键作用。

相似文献

1
Increased expression of vascular endothelial growth factor is associated with tumor progression in hepatocellular carcinoma.血管内皮生长因子表达增加与肝细胞癌的肿瘤进展相关。
Hum Pathol. 1998 Sep;29(9):986-91. doi: 10.1016/s0046-8177(98)90205-2.
2
Increased expression of vascular endothelial growth factor in human hepatocellular carcinoma.血管内皮生长因子在人肝细胞癌中的表达增加。
J Hepatol. 1997 Nov;27(5):854-61. doi: 10.1016/s0168-8278(97)80323-6.
3
Microvessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1/KDR in hepatocellular carcinoma.肝细胞癌中的微血管密度、血管内皮生长因子及其受体Flt-1和Flk-1/KDR
Am J Clin Pathol. 2001 Dec;116(6):838-45. doi: 10.1309/FXNL-QTN1-94FH-AB3A.
4
Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver.微血管密度和血管内皮生长因子表达在肝细胞癌及周围肝组织中的临床意义:血管内皮生长因子可能参与肝硬化肝脏的血管生成
Hepatology. 1998 Jun;27(6):1554-62. doi: 10.1002/hep.510270613.
5
Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma.缺氧诱导的胰岛素样生长因子II可能有助于人类肝细胞癌的血管生成。
Cancer Res. 1998 Jan 15;58(2):348-51.
6
Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor.血管内皮生长因子和碱性成纤维细胞生长因子基因表达在肝肿瘤中的临床意义
Hepatology. 1996 Mar;23(3):455-64. doi: 10.1053/jhep.1996.v23.pm0008617424.
7
Expression of vascular endothelial growth factor in surgical specimens of hepatocellular carcinoma.血管内皮生长因子在肝细胞癌手术标本中的表达
J Cancer Res Clin Oncol. 2000 Mar;126(3):153-60. doi: 10.1007/s004320050025.
8
Implications of human macrophage metalloelastase and vascular endothelial growth factor gene expression in angiogenesis of hepatocellular carcinoma.人类巨噬细胞金属弹性蛋白酶和血管内皮生长因子基因表达在肝细胞癌血管生成中的意义
Ann Surg. 2000 Jan;231(1):67-73. doi: 10.1097/00000658-200001000-00010.
9
Significance of vascular endothelial growth factor mRNA expression in invasion and metastasis of hepatocellular carcinoma.血管内皮生长因子mRNA表达在肝细胞癌侵袭和转移中的意义
J Exp Clin Cancer Res. 1998 Mar;17(1):13-7.
10
Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma.血管通透因子/血管内皮生长因子在人肝细胞癌中的表达
Cancer Res. 1996 Jul 1;56(13):3004-9.

引用本文的文献

1
CXCR2 expression is associated with prostate-specific membrane antigen expression in hepatocellular carcinoma: reappraisal of tumor microenvironment and angiogenesis.CXCR2表达与肝细胞癌中前列腺特异性膜抗原表达相关:肿瘤微环境与血管生成的重新评估
Clin Transl Oncol. 2025 Jun;27(6):2544-2556. doi: 10.1007/s12094-024-03789-7. Epub 2024 Dec 5.
2
Combination treatment for advanced hepatocellular carcinoma with portal vein tumour thrombus: A case report.中晚期合并门静脉癌栓肝癌的联合治疗:1 例报告。
J Int Med Res. 2021 Feb;49(2):300060521994406. doi: 10.1177/0300060521994406.
3
Reduction of FoxP3 Tregs by an immunosuppressive protocol of rapamycin plus Thymalfasin and Huaier extract predicts positive survival benefits in a rat model of hepatocellular carcinoma.
在肝癌大鼠模型中,采用雷帕霉素联合胸腺肽α1及槐耳提取物的免疫抑制方案降低FoxP3调节性T细胞可预测出积极的生存获益。
Ann Transl Med. 2020 Apr;8(7):472. doi: 10.21037/atm.2020.03.129.
4
The efficacy of immune checkpoint inhibitors in advanced non-small-cell lung cancer with liver metastases.免疫检查点抑制剂在伴肝转移的晚期非小细胞肺癌中的疗效。
J Cancer Res Clin Oncol. 2020 Mar;146(3):777-785. doi: 10.1007/s00432-019-03104-w. Epub 2019 Dec 11.
5
A Phase II, Multicenter, Single-Arm Study of Mipsagargin (G-202) as a Second-Line Therapy Following Sorafenib for Adult Patients with Progressive Advanced Hepatocellular Carcinoma.一项关于米泊沙星(G-202)作为索拉非尼治疗后二线疗法用于进展期成人肝细胞癌患者的II期多中心单臂研究。
Cancers (Basel). 2019 Jun 17;11(6):833. doi: 10.3390/cancers11060833.
6
Serum Liver-Type Fatty Acid-Binding Protein Is a Possible Prognostic Factor in Human Chronic Liver Diseases From Chronic Hepatitis to Liver Cirrhosis and Hepatocellular Carcinoma.血清肝型脂肪酸结合蛋白可能是人类慢性肝病(从慢性肝炎到肝硬化和肝细胞癌)的一个预后因素。
Hepatol Commun. 2019 Apr 2;3(6):825-837. doi: 10.1002/hep4.1350. eCollection 2019 Jun.
7
Subgroup analysis of efficacy and safety of orantinib in combination with TACE in Japanese HCC patients in a randomized phase III trial (ORIENTAL).随机 III 期临床试验(ORIENTAL)中奥瑞替尼联合 TACE 治疗日本 HCC 患者的疗效和安全性的亚组分析。
Med Oncol. 2019 May 3;36(6):52. doi: 10.1007/s12032-019-1272-2.
8
Emodin, a natural anthraquinone, suppresses liver cancer in vitro and in vivo by regulating VEGFR and miR-34a.大黄素是一种天然蒽醌类化合物,通过调节 VEGFR 和 miR-34a 抑制肝癌的体内外生长。
Invest New Drugs. 2020 Apr;38(2):229-245. doi: 10.1007/s10637-019-00777-5. Epub 2019 Apr 11.
9
From Desert to Medicine: A Review of Camel Genomics and Therapeutic Products.从沙漠到医学:骆驼基因组学与治疗产品综述
Front Genet. 2019 Feb 19;10:17. doi: 10.3389/fgene.2019.00017. eCollection 2019.
10
Anti-proliferative and anti-apoptotic potential effects of epigallocatechin-3-gallate and/or metformin on hepatocellular carcinoma cells: in vitro study.表没食子儿茶素-3-没食子酸酯和/或二甲双胍对肝癌细胞的抗增殖和抗凋亡潜在作用:体外研究
Mol Biol Rep. 2019 Apr;46(2):2039-2047. doi: 10.1007/s11033-019-04653-6. Epub 2019 Feb 1.